Intellijoint Surgical’s Scientific Advisory Board Welcomes New Member, Dr. Michael Bradley May 3, 2017
Intellijoint Surgical welcomes Dr. Michael Bradley, MD, MBA, MS, as the newest member to its Scientific Advisory Board (SAB). Dr. Bradley is Chief of Orthopaedics at South County Hospital in Wakefield, Rhode Island, and President/CEO of
Intellijoint Surgical Launches 1,000 Thanks to Celebrate 1,000 intellijoint HIP Procedures Apr 11, 2017
Intellijoint Surgical® is proud to announce that intellijoint HIP® has now - only one year after commercial launch - been used in over 1,000 total hip replacement procedures.
Intellijoint Surgical® Announces intellijoint HIP® Anterior Application FDA Clearance Mar 7, 2017
March 7, 2017 (Waterloo, Ontario) - Intellijoint Surgical® Inc., a privately-held Canadian medical technology company, announces FDA clearance of intellijoint HIP® Anterior, the newest application to the intellijoint HIP suite.